The Cost-Effectiveness of Using Platelet-Rich Plasma During Rotator Cuff Repair: A Markov Model Analysis

Samuelson, Eric M.; Odum, Susan M.; Fleischli, James E.

doi:10.1016/j.arthro.2015.12.018

Cited by 37 publications

(34 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Insurance companies still do not recognize PRP as standard of care, and thus PRP must be paid by patients out of pocket. It has been estimated recently that the cost of PRP is $500 to $1,500 per application 18 . It is important to have an open discussion regarding the cost of PRP injections, given that it may be prohibitively expensive for some patients.…”

Section: Decision-makingmentioning

confidence: 99%

The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders

Kraeutler

Garabekyan

Mei-Dan³

2019

Muscle Ligaments and Tendons J

View full text Add to dashboard Cite

Background: In recent years, platelet-rich plasma (PRP) has gained popularity within the orthopaedic community as a treatment modality to enhance tissue healing. Purpose: This review aims to concisely present the current indications for PRP injections in the treatment of hip and pelvic pathologies and to describe some novel applications for PRP which have not yet been reported in the literature. Methods: We reviewed the literature on the non-operative and operative indications for PRP in the treatment of hip and pelvic pathologies. Conclusions: With regard to hip and pelvic pathologies, PRP injections are used most commonly as a non-operative intervention, and have been described in the literature to treat osteoarthritis of the hip joint as well as tendinopathy of the hamstrings, adductor longus, and gluteus medius. In contrast, most of the surgical applications of PRP for the hip are novel, with few reported studies in the literature. Because of the increasing awareness of PRP's beneficial effects on musculoskeletal healing and thus the growing number of indications for its use, this review also describes some novel applications for PRP, including osteitis pubis, post-microfracture of the hip, tears of the rectus femoris, and avulsion of the sartorius muscle. Level of evidence: V.

show abstract

Section: Decision-makingmentioning

confidence: 99%

The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders

Kraeutler

Garabekyan

Mei-Dan³

2019

Muscle Ligaments and Tendons J

View full text Add to dashboard Cite

show abstract

“…The role of PRP in arthroscopic rotator cuff repair is the subject of the article by Samuelson et al, 7 but in the context of cost-effectiveness using a Markov model of analysis. When compared with conventional models, Markov models have more complex assumptions that forecast clinical problems by predicting decisions that involve continuous risk over time where the timing of events and potential repetition of events are important.…”

Section: See Related Article On Page 1237mentioning

confidence: 99%

Editorial Commentary: PRP: Platelet-Rich Plasma or Promising but Rarely Proven?

Lee

2016

Arthroscopy: The Journal of Arthroscopic & Related Surgery

View full text Add to dashboard Cite

Cost-utility analysis using a Markov decision model finds that platelet-rich plasma (PRP) is not cost-effective in rotator cuff repair because of no added outcomes benefit or improvement in retear rate according to best current evidence (Level I to III studies). To achieve the willingness-to-pay threshold, PRP would need to reduce rotator cuff retear rates. The authors have opened dialogue for us to determine what is the value and what should be the cost for PRP when it comes to rotator cuff repair.

show abstract

“…From analysis of current literature, this requires an additional absolute risk reduction in re-tear rates of 9.1%. 46 Overall, additional research is still needed to determine the utility of PRP as a biologic augment for RCR, particularly with respect to clinical outcomes, cost-effectiveness, and preparation type.…”

Section: Techniquementioning

confidence: 99%

“…Although initial pioneering investigations with both animal and human models have demonstrated that the potential for tendon regeneration, improved tendon integrity, and increased healing after BMAC augmentation may exist, the technology is still considered to be highly experimental and should not be included as part of any standard of care for rotator cuff repair based on available evidence. 1,2,8,9,13,46,45 At this time, additional clinical trials utilizing BMAC augmentation in rotator cuff repair are recommended in order to establish a possible role in future patient treatment.…”

Section: Indicationsmentioning

confidence: 99%

Biologic Augmentation of Rotator Cuff Repair: The Role of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate

Gowd

Cabarcas

Frank

et al. 2018

Operative Techniques in Sports Medicine

View full text Add to dashboard Cite

The Cost-Effectiveness of Using Platelet-Rich Plasma During Rotator Cuff Repair: A Markov Model Analysis

Cited by 37 publications

References 30 publications

The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders

The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders

Editorial Commentary: PRP: Platelet-Rich Plasma or Promising but Rarely Proven?

Biologic Augmentation of Rotator Cuff Repair: The Role of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate

Contact Info

Product

Resources

About